Press Note No. 2 (2015 Series) - Review of the policy on Foreign Direct Investment (FDI) in Pharmaceutical Sector- carve out for medical devices

Press Note No. 2 (2015 Series) - Review of the policy on Foreign Direct Investment (FDI) in Pharmaceutical Sector- carve out for medical devices https://www.taxtmi.com/news?id=13824 Revision permits full automatic FDI for manufacturing of medical devices, exempting those projects from the pharmaceutical FDI conditions such as non-compete restrictions, certificate requirements with FIPB applications, and possible brownfield conditions. The press note defines "medical device" to include instruments, apparatus, appliances, implants, materials, software and accessories for diagnostic, therapeutic, monitoring, investigational, life-support and in vitro diagnostic purposes, and states the definition is subject to amendment under the Drugs and Cosmetics Act. en-us Tue, 06 Jan 2015 18:59:15 +0530 Tue, 06 Jan 2015 18:59:15 +0530 TaxTMI RSS Generator Press Note No. 2 (2015 Series) - Review of the policy on Foreign Direct Investment (FDI) in Pharmaceutical Sector- carve out for medical devices https://www.taxtmi.com/news?id=13824 Revision permits full automatic FDI for manufacturing of medical devices, exempting those projects from the pharmaceutical FDI conditions such as non-compete restrictions, certificate requirements with FIPB applications, and possible brownfield conditions. The press note defines "medical device" to include instruments, apparatus, appliances, implants, materials, software and accessories for diagnostic, therapeutic, monitoring, investigational, life-support and in vitro diagnostic purposes, and states the definition is subject to amendment under the Drugs and Cosmetics Act. News - Tue, 06 Jan 2015 18:59:15 +0530 https://www.taxtmi.com/news?id=13824